Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-28

Clinical Trial Update: Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication [EARLY_Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Zuojin Wan in combination with Vonoprazan-amoxicillin dual therapy for Helicobacter pylori infection; the study is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Vonoprazan (vonoprazan)
  • Zuojin Wan

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Helicobacter Pylori Infection | EARLY_Phase 1 | Status: NOT_YET_RECRUITING